• Issue

    Arthritis & Rheumatism: Volume 46, Issue 10

    2549-2830, bmi
    October 2002
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorial

Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis?

A. Robin Poole, 
  • Pages: 2549-2552
  • First Published: 16 October 2002

Review

Glucocorticoids and rheumatoid arthritis: Back to the future?

Larry W. Moreland,  James R. O'Dell, 
  • Pages: 2553-2563
  • First Published: 16 October 2002

In Memoriam

E. Carwile LeRoy, MD, 1933–2002

Richard M. Silver, 
  • Page: 2564
  • First Published: 16 October 2002

Original Articles

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

Jong-Hoon Lee,  Nancy R. Slifman,  Sharon K. Gershon,  Evelyne T. Edwards,  William D. Schwieterman,  Jeffrey N. Siegel,  Robert P. Wise,  S. Lori Brown,  John N. Udall Jr.,  M. Miles Braun, 
  • Pages: 2565-2570
  • First Published: 16 October 2002

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

Ori Elkayam,  Philip N. Hawkins,  Helen Lachmann,  Michael Yaron,  Dan Caspi, 
  • Pages: 2571-2573
  • First Published: 16 October 2002

Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion†

Laura C. Rall,  Joseph M. Walsmith,  Laura Snydman,  Seymour Reichlin,  Johannes D. Veldhuis,  Joseph J. Kehayias,  Leslie W. Abad,  Nancy T. Lundgren,  Ronenn Roubenoff, 
  • Pages: 2574-2577
  • First Published: 16 October 2002

CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis

Norikuni Kawanaka,  Masahiro Yamamura,  Tetsushi Aita,  Yoshitaka Morita,  Akira Okamoto,  Masanori Kawashima,  Mitsuhiro Iwahashi,  Akiko Ueno,  Yasukazu Ohmoto,  Hirofumi Makino, 
  • Pages: 2578-2586
  • First Published: 16 October 2002

Hypoxia-induced production of stromal cell–derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts

Carol Hitchon,  Keng Wong,  Guoping Ma,  Jennifer Reed,  David Lyttle,  Hani El-Gabalawy, 
  • Pages: 2587-2597
  • First Published: 16 October 2002

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

R. Kokkola,  E. Sundberg,  A.-K. Ulfgren,  K. Palmblad,  J. Li,  H. Wang,  L. Ulloa,  H. Yang,  X.-J. Yan,  R. Furie,  N. Chiorazzi,  K. J. Tracey,  U. Andersson,  H. Erlandsson Harris, 
  • Pages: 2598-2603
  • First Published: 16 October 2002

Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis

Angela Coxon,  Brad Bolon,  Juan Estrada,  Stephen Kaufman,  Sheila Scully,  Alana Rattan,  Diane Duryea,  Yi-Ling Hu,  Karen Rex,  Efrain Pacheco,  Gwyneth Van,  Debra Zack,  Ulrich Feige, 
  • Pages: 2604-2612
  • First Published: 16 October 2002

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis

Patrick Garnero,  Xavier Ayral,  Jean-Charles Rousseau,  S. Christgau,  Linda J. Sandell,  Maxime Dougados,  Pierre D. Delmas, 
  • Pages: 2613-2624
  • First Published: 16 October 2002

Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip

Kensaku Masuhara,  Tsuyoshi Nakai,  Katsuyuki Yamaguchi,  Satoshi Yamasaki,  Yasuyuki Sasaguri, 
  • Pages: 2625-2631
  • First Published: 16 October 2002

The influence of alignment on risk of knee osteoarthritis progression according to baseline stage of disease

Rui Cerejo,  Dorothy D. Dunlop,  September Cahue,  David Channin,  Jing Song,  Leena Sharma, 
  • Pages: 2632-2636
  • First Published: 16 October 2002

The in situ up-regulation of chondrocyte interleukin-1–converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide

Christelle Boileau,  Johanne Martel-Pelletier,  Florina Moldovan,  Jean-Yves Jouzeau,  Patrick Netter,  Pamela T. Manning,  Jean-Pierre Pelletier, 
  • Pages: 2637-2647
  • First Published: 16 October 2002

Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro

Brigitte Bau,  Pia M. Gebhard,  Jochen Haag,  Thomas Knorr,  Eckart Bartnik,  Thomas Aigner, 
  • Pages: 2648-2657
  • First Published: 16 October 2002

Human intervertebral disc aggrecan inhibits nerve growth in vitro

William E. B. Johnson,  Bruce Caterson,  Stephen M. Eisenstein,  Dianna L. Hynds,  Diane M. Snow,  Sally Roberts, 
  • Pages: 2658-2664
  • First Published: 16 October 2002

Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus

G. P. Th. Bosma,  H. A. M. Middelkoop,  M. J. Rood,  E. L. E. M. Bollen,  T. W. J. Huizinga,  M. A. Van Buchem, 
  • Pages: 2665-2672
  • First Published: 16 October 2002

An open study of B lymphocyte depletion in systemic lupus erythematosus

Maria J. Leandro,  Jonathan C. Edwards,  Geraldine Cambridge,  Michael R. Ehrenstein,  David A. Isenberg, 
  • Pages: 2673-2677
  • First Published: 16 October 2002

Familiality and co-occurrence of clinical features of systemic lupus erythematosus

Betty P. Tsao,  Jennifer M. Grossman,  Gabriela Riemekasten,  Noel Strong,  Jatinderpal Kalsi,  Daniel J. Wallace,  Chung-Jen Chen,  Chak S. Lau,  Ellen M. Ginzler,  Rose Goldstein,  Kenneth C. Kalunian,  John B. Harley,  Frank C. Arnett,  Bevra H. Hahn,  Rita M. Cantor, 
  • Pages: 2678-2685
  • First Published: 16 October 2002

Antibodies to high-density lipoprotein and β2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

J. Delgado Alves,  P. R. J. Ames,  S. Donohue,  L. Stanyer,  J. Noorouz-Zadeh,  C. Ravirajan,  D. A. Isenberg, 
  • Pages: 2686-2694
  • First Published: 16 October 2002

Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: Lack of evidence for a direct role of lamin B1 in apoptotic blebs

Mélanie Dieudé,  Jean-Luc Senécal,  Joyce Rauch,  John G. Hanly,  Paul Fortin,  Nathalie Brassard,  Yves Raymond, 
  • Pages: 2695-2707
  • First Published: 16 October 2002

The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis

Mohammad J. Al-Matar,  Ross E. Petty,  Lori B. Tucker,  Peter N. Malleson,  Maria-Louise Schroeder,  David A. Cabral, 
  • Pages: 2708-2715
  • First Published: 16 October 2002

Evidence for linkage of HLA loci in juvenile idiopathic oligoarthritis: Independent effects of HLA–A and HLA–DRB1

Eleftheria Zeggini,  Rachelle P. Donn,  William E. R. Ollier,  Wendy Thomson,  The British Paediatric Rheumatology Study Group , 
  • Pages: 2716-2720
  • First Published: 16 October 2002

Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis

Margherita Massa,  Federica Mazzoli,  Patrizia Pignatti,  Fabrizio De Benedetti,  Maristella Passalia,  Stefania Viola,  Rodrigo Samodal,  Antonio La Cava,  Francesca Giannoni,  W. Ollier,  Alberto Martini,  Salvatore Albani, 
  • Pages: 2721-2729
  • First Published: 16 October 2002

Involvement of the interferon-γ–induced T cell–attracting chemokines, interferon-γ–inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome

Noriyoshi Ogawa,  Li Ping,  Li Zhenjun,  Yukiko Takada,  Susumu Sugai, 
  • Pages: 2730-2741
  • First Published: 16 October 2002

Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: Application to enzyme-linked immunosorbent assay

Masataka Kuwana,  Kyoko Kimura,  Yutaka Kawakami, 
  • Pages: 2742-2747
  • First Published: 16 October 2002

Halofuginone inhibition of COL1A2 promoter activity via a c-Jun–dependent mechanism

Tracy L. McGaha,  Takao Kodera,  Harry Spiera,  Alexandru C. Stan,  Mark Pines,  Constantin A. Bona, 
  • Pages: 2748-2761
  • First Published: 16 October 2002

Symptomatic macroglossia and tongue myositis in polymyositis: Treatment with corticosteroids and intravenous immunoglobulin

E. Chauvet,  L. Sailler,  M. Carreiro,  J. R. Paoli,  P. Arrue,  L. Astudillo,  F. Oksmann,  M. B. Delisle,  Ph. Arlet, 
  • Pages: 2762-2764
  • First Published: 16 October 2002

Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis

Stephen J. Getting,  Helen C. Christian,  Roderick J. Flower,  Mauro Perretti, 
  • Pages: 2765-2775
  • First Published: 16 October 2002

Alefacept treatment in psoriatic arthritis: Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis

Maarten C. Kraan,  Arno W. R. van Kuijk,  Huibert J. Dinant,  Amber Y. Goedkoop,  Tom J. M. Smeets,  Menno A. de Rie,  Ben A. C. Dijkmans,  Akshay K. Vaishnaw,  Jan D. Bos,  Paul P. Tak, 
  • Pages: 2776-2784
  • First Published: 16 October 2002

Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever

Cécile Notarnicola,  Marie-Noëlle Didelot,  Isabelle Koné-Paut,  Fabienne Seguret,  Jacques Demaille,  Isabelle Touitou, 
  • Pages: 2785-2793
  • First Published: 16 October 2002

Lack of isoprenoid products raises ex vivo interleukin-1β secretion in hyperimmunoglobulinemia D and periodic fever syndrome

Joost Frenkel,  Ger T. Rijkers,  Saskia H. L. Mandey,  Sandra W. M. Buurman,  Sander M. Houten,  Ronald J. A. Wanders,  Hans R. Waterham,  Wietse Kuis, 
  • Pages: 2794-2803
  • First Published: 16 October 2002

Radiologic Vignette

Radiographic healing with sustained clinical remission in a patient with rheumatoid arthritis receiving methotrexate monotherapy

Siegfried Wassenberg,  Rolf Rau, 
  • Pages: 2804-2807
  • First Published: 16 October 2002

Osteoid osteoma of the capitate

Andreas Schindler,  Juerg Hodler,  Beat A. Michel,  Pius Bruehlmann, 
  • Pages: 2808-2810
  • First Published: 16 October 2002

Concise Communication

Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis

Christian A. Seemayer MD,  Stefan A. Kolb MD,  Michel Neidhart PhD,  Shiro Ohshima MD,  Renate E. Gay MD,  Beat A. Michel MD,  Steffen Gay MD,  Jürg Böni DVM,  Jörg Schüpbach MD, 
  • Pages: 2811-2813
  • First Published: 16 October 2002

Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease

Adam S. Greenstein MRCP,  Helena Marzo-Ortega MRCP,  Paul Emery MA, MD, FRCP,  Philip O'Connor FRCR,  Dennis McGonagle MRCPI, 
  • Pages: 2814-2815
  • First Published: 16 October 2002

Clinical Images

Clinical image: Crystal-induced arthritis mimicking rheumatoid arthritis in a patient with monoclonal gammopathy

H. Aarset MD,  J. Dekker MD,  S.-H. Brorson PhD,  G. Husby MD, PhD, 
  • Page: 2816
  • First Published: 16 October 2002

Letter

Blocking tumor necrosis factor inhibits radiographic damage even in patients who show minimal or no clinical improvement: Comment on the concise communication by Boers

Peter E. Lipsky MD,  David T. Felson MD, MPH,  Ravinder N. Maini MD, FRCP, 
  • Pages: 2817-2818
  • First Published: 16 October 2002

Reply

Maarten Boers MSc, MD, PhD, 
  • Pages: 2818-2820
  • First Published: 16 October 2002

Comment on the reply by Boers

Peter E. Lipsky MD,  Ravinder N. Maini MD, FRCP, 
  • Pages: 2820-2821
  • First Published: 16 October 2002

Case series of selective anti–tumor necrosis factor α therapy using infliximab in patients with nonresponsive chronic HLA–B27–associated anterior uveitis: Comment on the articles by Brandt et al

Yosuf El-Shabrawi MD,  Josef Hermann MD, 
  • Pages: 2821-2822
  • First Published: 16 October 2002

Reply

Jürgen Braun MD,  Joachim Sieper MD, 
  • Pages: 2822-2824
  • First Published: 16 October 2002

Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al

T. J. M. Smeets BSc,  E. R. Vossenaar,  W. J. van Venrooij PhD,  P. P. Tak MD, PhD, 
  • Pages: 2824-2826
  • First Published: 16 October 2002

Reply

Dominique Baeten MD, PhD,  Eric M. Veys MD, PhD,  Filip De Keyser MD, PhD, 
  • Pages: 2826-2827
  • First Published: 16 October 2002

Is acquired C1 inhibitor deficiency associated with lupus a distinct disease entity? Comment on the article by Cacoub et al

Aamir Aslam BSc, MRCP,  Siraj A. Misbah MSc, FRCP, FRCPath, 
  • Pages: 2827-2828
  • First Published: 16 October 2002

Reply

Patrice Cacoub MD,  Véronique Frémeaux-Bacchi MD, 
  • Page: 2828
  • First Published: 16 October 2002

Is the Sp1 polymorphism in the COL1A1 gene a risk factor for postmenopausal osteoporosis? Comment on the article by Keen et al

K. Zajíc̆ková MD,  I. Žofková MD, PhD, DSc,  M. Hill PhD, DSc, 
  • Pages: 2828-2829
  • First Published: 16 October 2002

Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases

Monty B. Tew MD,  Frank C. Arnett MD,  John D. Reveille MD,  Filemon K. Tan MD, PhD, 
  • Pages: 2829-2830
  • First Published: 16 October 2002

Erratum

Free Access

Erratum

  • Page: 2830
  • First Published: 16 October 2002

Announcements

ACR announcements

  • Page: bmi
  • First Published: 16 October 2002